Skip to main content

and
  1. No Access

    Article

    Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine

    Occult breast cancer presenting with axillary lymph node metastases is uncommon, and inflammatory breast cancer (IBC), as a subtype, is quite rare. Here we describe a case of IBC, which arose as an unknown pri...

    Hirofumi Asakura, Hitoshi Takashima in International Journal of Clinical Oncology (2005)

  2. No Access

    Article

    Usefulness of FDG-PET imaging for the radiotherapy treatment planning of pyothorax-associated lymphoma

    Pyothorax-associated lymphoma (PAL) is a non-Hodgkin’s lymphoma develo** in the pleural cavity after a long-standing history of chronic pyothorax (CP). F-18 fluorodeoxyglucose positron emission tomography (F...

    Hirofumi Asakura, Taro Togami, Masahiro Mitani in Annals of Nuclear Medicine (2005)

  3. No Access

    Article

    Palliative radiotherapy for bleeding from advanced gastric cancer: is a schedule of 30 Gy in 10 fractions adequate?

    To evaluate the effectiveness of short-course radiotherapy (RT) with 30 Gy in 10 fractions for bleeding from advanced gastric cancer.

    Hirofumi Asakura, Takayuki Hashimoto in Journal of Cancer Research and Clinical On… (2011)

  4. Article

    Open Access

    Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey

    The patterns of radiotherapy (RT) practice for biliary tract cancer (BTC) in Japan are not clearly established.

    Fumiaki Isohashi, Kazuhiko Ogawa, Hirobumi Oikawa, Hiroshi Onishi in Radiation Oncology (2013)

  5. Article

    Open Access

    Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas

    To compare proton beam therapy (PBT) and intensity-modulated radiation therapy (IMRT) with conformal radiation therapy (CRT) in terms of their organ doses and ability to cause secondary cancer in normal organs.

    Hiroshi Fuji, Uwe Schneider, Yuji Ishida, Masahiro Konno in Radiation Oncology (2013)

  6. No Access

    Article

    Feasibility of extended-field irradiation and intracavitary brachytherapy combined with weekly cisplatin chemosensitization for IB2–IIIB cervical cancer with positive paraaortic or high common iliac lymph nodes: a retrospective review

    The aim of this retrospective study was to investigate the feasibility of primary treatment with extended-field irradiation and weekly cisplatin (extended-field concurrent chemoradiotherapy, EFCCRT) as initial...

    Shiho Kuji, Yasuyuki Hirashima, Satomi Komeda in International Journal of Clinical Oncology (2014)

  7. Article

    Open Access

    Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study

    Re-irradiation (re-RT) of the thorax is challenging due to the impact of prior therapies on normal tissues, and there are few reports of definitive re-RT. The treatment toxicities and efficacy of re-RT are not...

    Kiyomi Sumita, Hideyuki Harada, Hirofumi Asakura, Hirofumi Ogawa in Radiation Oncology (2016)

  8. Article

    Open Access

    Retrospective analysis of salvage surgery for local progression of brain metastasis previously treated with stereotactic irradiation: diagnostic contribution, functional outcome, and prognostic factors

    Stereotactic irradiation (STI) is a primary treatment for patients with newly diagnosed brain metastases. Some of these patients experience local progression, which is difficult to differentiate from radiation...

    Koichi Mitsuya, Yoko Nakasu, Nakamasa Hayashi, Shoichi Deguchi, Takuma Oishi in BMC Cancer (2020)

  9. No Access

    Article

    Surgical outcome and graded prognostic assessment of patients with brain metastasis from adult sarcoma: multi-institutional retrospective study in Japan

    Brain metastasis (BM) is an uncommon complication of sarcomas with a poor prognosis. Little information is available about the feasibility and prognostic factors of surgical resection of BM from sarcomas.

    Shoichi Deguchi, Yoko Nakasu, Tsukasa Sakaida in International Journal of Clinical Oncology (2020)

  10. Article

    Open Access

    Neoadjuvant fractionated stereotactic radiotherapy followed by piecemeal resection of brain metastasis: a case series of 20 patients

    The safety and effectiveness of neoadjuvant fractionated stereotactic radiotherapy (FSRT) before piecemeal resection of brain metastasis (BM) remains unknown.

    Shoichi Deguchi, Koichi Mitsuya in International Journal of Clinical Oncology (2022)

  11. Article

    Open Access

    Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases

    Linac-based fractionated stereotactic radiotherapy (fSRT) and stereotactic radiosurgery (SRS) are increasingly being used to manage patients with multiple metastases. This retrospective cohort study aimed to c...

    Masanori Hirata, Kazuaki Yasui, Naofumi Oota, Hirofumi Ogawa in Radiation Oncology (2022)

  12. Article

    Open Access

    Correction: Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases

    Masanori Hirata, Kazuaki Yasui, Naofumi Oota, Hirofumi Ogawa in Radiation Oncology (2023)

  13. No Access

    Article

    Significance of radiation therapy in the myxoid round-cell liposarcoma treatment regimen

    Because myxoid liposarcomas are more radiosensitive than other soft tissue sarcomas, there have been several reports of 50 Gy preoperative radiation therapy combined with surgery, but the wound complication ra...

    Akiyoshi Shimatani, Hirohisa Katagiri in International Journal of Clinical Oncology (2024)